HONORHEALTH DEER VALLEY MED CTR
1. Target Overview & Investment Thesis
HONORHEALTH DEER VALLEY MED CTR is a 204-bed suburban community hospital in MARICOPA, AZ with $372.1M in net patient revenue and a 3.3% operating margin. The hospital serves a payer mix of 24.2% Medicare, 22.3% Medicaid, and 53.5% commercial.
Thesis: Undervalued. Our ML models identify $27.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.3% to 10.7% (+736bps).
| Net Revenue HCRIS | $372.1M |
| Current EBITDA COMPUTED | $12.3M |
| Operating Margin COMPUTED | 3.3% |
| Occupancy HCRIS | 78.3% |
| Revenue / Bed COMPUTED | $1.8M |
| Net-to-Gross HCRIS | 15.8% |
| Distress Probability ML | 43.8% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 3.3% places it above the state median. Among 38 size-comparable peers (102-408 beds), the median margin is 1.1%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (102-408), prioritizing same-state peers. 38 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HONORHEALTH DEER VALLEY MED CT (Target) | AZ | 204 | $372.1M | 3.3% |
| MAYO CLINIC HOSPITAL | AZ | 315 | $2.25B | 1.4% |
| BANNER ESTRELLA MEDICAL CENTER | AZ | 317 | $1.84B | 79.2% |
| BANNER BAYWOOD MEDICAL CENTER | AZ | 323 | $1.39B | 79.1% |
| PHOENIX CHILDRENS HOSPITAL | AZ | 352 | $1.26B | 6.0% |
| YUMA REGIONAL MEDICAL CENTER | AZ | 406 | $670.8M | 6.3% |
| HONORHEALTH JOHN C. LINCOLN ME | AZ | 258 | $618.4M | -7.9% |
| BANNER GATEWAY MEDICAL CENTER | AZ | 185 | $573.8M | 5.2% |
| VALLEYWISE HEALTH MEDICAL CENT | AZ | 301 | $509.4M | -50.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $27.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $7.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $7.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $7.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $4.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $238K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $12.3M |
| + RCM Uplift | +$27.4M |
| Pro Forma EBITDA | $39.7M |
| Current Margin | 3.3% |
| Pro Forma Margin | 10.7% |
| WC Released (1x) | $14.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $18.9M | $355.0M | 18.78x | 79.8% |
| Base (11x exit) | 10.0x | 11.0x | $18.9M | $396.6M | 20.99x | 83.8% |
| Bull Case | 9.0x | 11.0x | $17.0M | $493.1M | 28.99x | 96.1% |
| Bull (12x exit) | 9.0x | 12.0x | $17.0M | $543.0M | 31.92x | 99.9% |
| Bear Case | 11.0x | 10.0x | $20.8M | $211.9M | 10.19x | 59.1% |
| Bear (11x exit) | 11.0x | 11.0x | $20.8M | $239.8M | 11.53x | 63.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (22.3%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 38 hospitals with 102-408 beds
- Same-state prioritization (n=39)
- Comp margins: P25=-6.2% / P50=1.1% / P75=13.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.